Kovelman Harry
Chief Medical Officer
Kovelman Harry has filed 9 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2026. 9 of those filings fall inside the rolling window. Most recent filing: Oct 15, 2026.
On the most recent filing, Kovelman Harry is listed as Chief Medical Officer at MYOMO, INC. Inside the rolling window, Kovelman Harry reported no open-market purchases and 4 open-market sales totaling $132K in MYO. The largest disclosed transaction in the window is a sale of 34,750 MYO shares on Aug 20, 2026, worth $60K.
Companies traded
Other insiders at MYO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$132K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kovelman Harry made?
Kovelman Harry has filed 9 SEC Form 4 filings (11 transaction rows) across 1 company since 2026.
Which companies does Kovelman Harry trade?
Kovelman Harry has filed SEC Form 4 disclosures for 1 company, including MYO.
When was Kovelman Harry's most recent SEC Form 4 filing?
Kovelman Harry's most recent SEC Form 4 filing on Tracefour is dated Oct 15, 2026.
What is Kovelman Harry's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kovelman Harry is listed as Chief Medical Officer.
What is Kovelman Harry's total buy and sell value in the current window?
Inside the rolling retention window, Kovelman Harry bought $0 and sold $132K based on SEC Form 4 filings.
What was Kovelman Harry's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 34,750 MYO shares on 2026-08-20, worth $60K, per SEC Form 4 filings.